Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3710)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
916
Price
$545.66
Total Value
$499.83K
Shares Held After
48,606
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
491
Price
$544.69
Total Value
$267.44K
Shares Held After
49,522
% of Holdings
1.0%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
8,034
Price
$65.24
Total Value
$524.16K
Shares Held After
1,564,407
% of Holdings
0.5%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
64,500
Price
$64.27
Total Value
$4.15M
Shares Held After
1,572,441
% of Holdings
3.9%
Acumen Pharmaceuticals, Inc. (ABOS)
Fountain Nathan B — Director
Shares
6,400
Price
$2.23
Total Value
$14.27K
Shares Held After
48,150
% of Holdings
11.7%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
31,916
Price
$5.30
Total Value
$169.29K
Shares Held After
1,374,079
% of Holdings
2.3%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
5,450
Price
$5.30
Total Value
$28.91K
Shares Held After
303,451
% of Holdings
1.8%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
6,305
Price
$5.30
Total Value
$33.44K
Shares Held After
440,003
% of Holdings
1.4%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
25,646
Price
$5.39
Total Value
$138.29K
Shares Held After
518,437
% of Holdings
4.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
13,421
Price
$5.30
Total Value
$71.19K
Shares Held After
544,083
% of Holdings
2.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$0.85
Total Value
$4.25K
Shares Held After
298,266
% of Holdings
1.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$67.98
Total Value
$237.93K
Shares Held After
153,902
% of Holdings
2.2%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
5,000
Price
$11.79
Total Value
$58.95K
Shares Held After
9,005
% of Holdings
55.5%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
49,670
Price
$241.01
Total Value
$11.97M
Shares Held After
7,229
% of Holdings
87.3%
Axsome Therapeutics, Inc. (AXSM)
Pizzie Nick — Chief Financial Officer
Shares
33,000
Price
$240.09
Total Value
$7.92M
Shares Held After
42,867
% of Holdings
43.5%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
1,423,493
Price
$0.05
Total Value
$69.75K
Shares Held After
1,193,333
% of Holdings
119.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
2,982
Price
$1.52
Total Value
$4.53K
Shares Held After
72,535
% of Holdings
4.1%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
29,518
Price
$1.52
Total Value
$44.87K
Shares Held After
718,444
% of Holdings
4.1%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
5,893
Price
$4.38
Total Value
$25.81K
Shares Held After
167,331
% of Holdings
3.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
6,515
Price
$94.03
Total Value
$612.61K
Shares Held After
258,917
% of Holdings
2.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,120
Price
$271.14
Total Value
$303.68K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,820
Price
$270.38
Total Value
$1.03M
Shares Held After
1,120
% of Holdings
77.3%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
36
Price
$272.08
Total Value
$9.79K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
100
Price
$271.06
Total Value
$27.11K
Shares Held After
36
% of Holdings
73.5%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
40
Price
$270.55
Total Value
$10.82K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,444
Price
$269.33
Total Value
$388.92K
Shares Held After
40
% of Holdings
97.3%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
160
Price
$271.26
Total Value
$43.40K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
711
Price
$270.24
Total Value
$192.14K
Shares Held After
160
% of Holdings
81.6%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
40
Price
$270.73
Total Value
$10.83K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,327
Price
$269.34
Total Value
$357.42K
Shares Held After
40
% of Holdings
97.1%
Liquidia Corp (LQDA)
Khindri Sanjeev — Chief Development Officer
Shares
4,134
Price
$65.46
Total Value
$270.61K
Shares Held After
67,132
% of Holdings
5.8%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
2,804
Price
$66.19
Total Value
$185.59K
Shares Held After
1,636,941
% of Holdings
0.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
39,187
Price
$65.38
Total Value
$2.56M
Shares Held After
1,639,745
% of Holdings
2.3%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
106,310
Price
$64.49
Total Value
$6.86M
Shares Held After
1,678,932
% of Holdings
6.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
3,036
Price
$89.63
Total Value
$272.12K
Shares Held After
324,879
% of Holdings
0.9%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
14,469
Price
$88.79
Total Value
$1.28M
Shares Held After
327,915
% of Holdings
4.2%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
12,495
Price
$87.97
Total Value
$1.10M
Shares Held After
342,384
% of Holdings
3.5%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,567
Price
$95.12
Total Value
$149.05K
Shares Held After
44,788
% of Holdings
3.4%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,175
Price
$93.95
Total Value
$110.39K
Shares Held After
46,355
% of Holdings
2.5%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
2,258
Price
$92.84
Total Value
$209.63K
Shares Held After
47,530
% of Holdings
4.5%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
24,428
Price
$5.43
Total Value
$132.63K
Shares Held After
1,405,995
% of Holdings
1.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
4,170
Price
$5.43
Total Value
$22.64K
Shares Held After
308,901
% of Holdings
1.3%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
10,271
Price
$5.43
Total Value
$55.77K
Shares Held After
557,504
% of Holdings
1.8%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
4,826
Price
$5.43
Total Value
$26.20K
Shares Held After
446,308
% of Holdings
1.1%
FRACTYL HEALTH, INC. (GUTS)
Smith Weber Lara — Chief Financial Officer
Shares
20,000
Price
$0.69
Total Value
$13.71K
Shares Held After
20,000
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$551.75
Total Value
$44.14K
Shares Held After
18,876
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
610
Price
$551.28
Total Value
$336.28K
Shares Held After
18,956
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,285
Price
$550.09
Total Value
$706.87K
Shares Held After
19,566
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
425
Price
$549.38
Total Value
$233.49K
Shares Held After
20,851
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,158
Price
$547.91
Total Value
$1.18M
Shares Held After
21,276
% of Holdings
9.2%
Showing 1101–1150 of 3710 transactions (page 23 of 75)